Cargando…

Controversies on Rituximab Therapy in Sjögren Syndrome-Associated Lymphoproliferation

Sjögren's syndrome (SS) is a systemic autoimmune disease characterized by chronic inflammation of salivary and lachrymal glands, and frequently accompanied by systemic symptoms. A subgroup of SS patients develops malignant B cell non-Hodgkin's lymphoma (NHL), usually of the mucosa-associat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quartuccio, Luca, Fabris, Martina, Salvin, Sara, Maset, Marta, De Marchi, Ginevra, De Vita, Salvatore
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2009
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817502/ https://www.ncbi.nlm.nih.gov/pubmed/20148068 http://dx.doi.org/10.1155/2009/424935

Ejemplares similares

Comment on: “SARS CoV-2 vaccine AND rituximab, timing is probably a key for a better vaccine response” by Verhoeven et al. Joint Bone Spine 2021;88:105258
por: De Marchi, Ginevra, et al.
Publicado: (2022)

Resistance to Rituximab Therapy and Local BAFF Overexpression in Sjögren’s Syndrome-Related Myoepithelial Sialadenitis and Low-Grade Parotid B-Cell Lymphoma
por: Quartuccio, Luca, et al.
Publicado: (2008)

High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients
por: Fabris, Martina, et al.
Publicado: (2022)

Shared Pathogenetic Features Between Common Variable Immunodeficiency and Sjögren’s Syndrome: Clues for a Personalized Medicine
por: Quartuccio, Luca, et al.
Publicado: (2021)

NKp30 Receptor Upregulation in Salivary Glands of Sjögren’s Syndrome Characterizes Ectopic Lymphoid Structures and Is Restricted by Rituximab Treatment
por: Pontarini, Elena, et al.
Publicado: (2021)

Sjögren syndrome: looking forward to the future
por: Zandonella Callegher, Sara, et al.
Publicado: (2022)

Normal-Appearing Salivary Gland Ultrasonography Identifies a Milder Phenotype of Primary Sjögren's Syndrome
por: Zandonella Callegher, Sara, et al.
Publicado: (2020)

Ultrasound and Bioptic Investigation of Patients with Primary Sjögren’s Syndrome
por: Manfrè, Valeria, et al.
Publicado: (2021)

HCV and Lymphoproliferation
por: Zignego, Anna Linda, et al.
Publicado: (2012)

Rituximab Therapy for Primary Sjögren’s Syndrome
por: Chen, Yi Han, et al.
Publicado: (2021)

Rituximab Induction and Maintenance in ANCA-Associated Vasculitis: State of the Art and Future Perspectives
por: Treppo, Elena, et al.
Publicado: (2021)

Risk of Cancer in Connective Tissue Diseases in Northeastern Italy over 15 Years
por: Treppo, Elena, et al.
Publicado: (2022)

Articular and Peripheral Nervous System Involvement Are Linked to the Long-Term Outcome in Primary Sjögren's Syndrome: The Relevance of Single Organ Manifestations Rather Than a Composite Score as Predictors
por: Quartuccio, Luca, et al.
Publicado: (2019)

Peripheral Nervous System Involvement in Sjögren’s Syndrome: Analysis of a Cohort From the Italian Research Group on Sjögren’s Syndrome
por: Cafaro, Giacomo, et al.
Publicado: (2021)

Serum levels of anti-CCP antibodies, anti-MCV antibodies and RF IgA in the follow-up of patients with rheumatoid arthritis treated with rituximab
por: Fabris, Martina, et al.
Publicado: (2010)

Diagnosis and management of lung involvement in systemic lupus erythematosus and Sjögren’s syndrome: a literature review
por: Depascale, Roberto, et al.
Publicado: (2021)

A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren’s syndrome
por: Mariette, Xavier, et al.
Publicado: (2022)

Severe Headache in Primary Sjögren’s Syndrome Responded to Rituximab
por: Kudsi, Maysoun, et al.
Publicado: (2023)

Safety, patient acceptance and diagnostic accuracy of ultrasound core needle biopsy of parotid or submandibular glands in primary Sjögren’s syndrome with suspected salivary gland lymphoma
por: Giovannini, Ivan, et al.
Publicado: (2022)

Diffuse skin hyperpigmentation in CD30+ lymphoproliferation
por: Prka, Zeljko, et al.
Publicado: (2012)

Severe headache in primary Sjögren’s syndrome treated with intrathecal rituximab
por: Tjensvoll, Anne Bolette, et al.
Publicado: (2019)

Humoral and T-Cell Mediated Response after the Third Dose of mRNA Vaccines in Patients with Systemic Lupus Erythematosus on Belimumab
por: Quartuccio, Luca, et al.
Publicado: (2023)

Patient Experiences of Systemic Lupus Erythematosus: Findings From a Systematic Review, Meta‐Summary, and Meta‐Synthesis
por: Petrocchi, Valentina, et al.
Publicado: (2022)

Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice
Publicado: (1993)

The tumor microenvironment may trigger lymphoproliferation in cardiac myxoma
por: Jantuan, Eugeniu, et al.
Publicado: (2020)

Genetic heterogeneity of pediatric systemic lupus erythematosus with lymphoproliferation
por: Li, Guomin, et al.
Publicado: (2020)

NCKAP1L defects lead to a novel syndrome combining immunodeficiency, lymphoproliferation, and hyperinflammation
por: Castro, Carla Noemi, et al.
Publicado: (2020)

Persistence and selection of an expanded B-cell clone in the setting of rituximab therapy for Sjögren’s syndrome
por: Hershberg, Uri, et al.
Publicado: (2014)

Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation
por: Soares, Andreia, et al.
Publicado: (2010)

Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome
por: Quartuccio, Luca, et al.
Publicado: (2020)

Detection of EBV in reactive and neoplastic lymphoproliferations in adults—when and how?
por: Stuhlmann-Laeisz, Christiane, et al.
Publicado: (2014)

PB2166: TET ENZYMES PROTECT AGAINST FATAL LYMPHOPROLIFERATION
por: Spoeck, S., et al.
Publicado: (2022)

Rituximab for Sjögren syndrome–associated type II mixed cryoglobulinemic cerebral vasculitis
por: Lioger, Bertrand, et al.
Publicado: (2016)

Primary-Sjögren’s-Syndrome-Related Interstitial Lung Disease: A Clinical Review Discussing Current Controversies
por: La Rocca, Gaetano, et al.
Publicado: (2023)

Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care
por: Quartuccio, Luca, et al.
Publicado: (2020)

Answer to Vieira et al. “Cytokine profile as a prognostic tool in coronavirus disease 2019”. Joint Bone Spine 2020. Doi:10.1016/j.jbspin.2020.09.006
por: Quartuccio, Luca, et al.
Publicado: (2021)

Lymphoproliferation Impairment and Oxidative Stress in Blood Cells from Early Parkinson’s Disease Patients
por: Vida, Carmen, et al.
Publicado: (2019)

Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity
por: Goudy, Kevin, et al.
Publicado: (2013)

Pistes urgentes dans le traitement de l’infection par le COVID-19 : cibler l’inflammation en aval pour prévenir un syndrome catastrophique()
por: Quartuccio, Luca, et al.
Publicado: (2020)

Salivary Gland Ultrasound in Primary Sjögren’s Syndrome: Current and Future Perspectives
por: Lorenzon, Michele, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f2hjejtpjo93g75f50u5su2kms